Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis

IMPORTANCE: Checkpoint inhibitors have replaced docetaxel as the new standard second-line therapy in advanced non–small cell lung carcinoma (NSCLC), but little is known about the potential predictive value of clinical and molecular characteristics. OBJECTIVE: To estimate the relative efficacy of che...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Lee, Chee Khoon, Man, Johnathan, Lord, Sally, Cooper, Wendy, Links, Matthew, Gebski, Val, Herbst, Roy S., Gralla, Richard J., Mok, Tony, Yang, James Chih-Hsin
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838598/
https://ncbi.nlm.nih.gov/pubmed/29270615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.4427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados